Hematinics: Clinical Trials

3 trials of Hematinics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3

Follow Hematinics: new trials by email Literature Review of Hematinics trials Research Report on Hematinics

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis
Erythropoiesis-Stimulating Agent (ESA), Vadadustat - Anemia of Chronic Kidney Disease
Phase 3CompletedAkebia Therapeutics3532025-07-242026-11-16
Vafseo Outcomes In-Center Experience
Vadadustat, Erythropoiesis Stimulating Agent - Anemia of Chronic Kidney Disease
Phase 3CompletedUSRC Kidney Research21162024-11-202026-11-12
The Clinical Evaluation of the Dose of Erythropoietins Trial
Erythropoiesis Stimulating Agents (ESAs): epoetin alfa, beta or any other epoetin in equivalent dose. - Kidney Failure, Chronic
Phase 3CompletedGiovanni FM Strippoli, MD6562009-07-012016-07-19

Conditions studied

Kidney Failure, Chronic (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

Akebia Therapeutics (1)  ·  Giovanni FM Strippoli, MD (1)  ·  USRC Kidney Research (1)

Countries

United States (2)  ·  Italy (1)

Top investigators

Giovanni FM Strippoli, MD (1)

Results publications

PMID 23832463

NIH funding

2008 (1)